BRNS
Barinthus Biotherapeutics plc$0.75+0.00 (—)Prev Close$0.76·MCap$22.9M·P/E—·Vol—·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$0.00
●
Active Insiders
0
last 12 mo
BRNS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Scheeren Joseph | Director | Buy | 10,000 | $2.44 | $24.4K | 0 |
| May 25, 2023 | Wright Robin | Director | Buy | 13,750 | $2.66 | $36.6K | 0 |
| Mar 27, 2023 | Enright William | Chief Executive Officer | Sell | 15,000 | $2.42 | $36.3K | 0 |
| Aug 25, 2022 | Griffiths Graham | Chief Business Officer | Sell | 10,000 | $7.39 | $73.9K | 0 |
| Aug 24, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 39,626 | $6.55 | $259.5K | 0 |
| Aug 17, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 2,824 | $4.82 | $13.6K | 0 |
| Aug 17, 2022 | Griffiths Graham | Chief Business Officer | Sell | 500 | $4.76 | $2.4K | 0 |
| Aug 15, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 7,550 | $4.77 | $36.0K | 0 |
| Aug 15, 2022 | Griffiths Graham | Chief Business Officer | Sell | 3,620 | $4.77 | $17.3K | 0 |
| Aug 12, 2022 | Griffiths Graham | Chief Business Officer | Sell | 5,000 | $4.50 | $22.5K | 0 |
| Jun 28, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 5 | $6.00 | $30.00 | 0 |
| Jun 23, 2022 | Griffiths Graham | Chief Business Officer | Sell | 108 | $5.82 | $629.04 | 0 |
| Apr 1, 2022 | Scheeren Joseph | Director | Buy | 10,000 | $5.09 | $50.9K | 0 |
| Mar 31, 2022 | Hammacher Alex | Director | Buy | 2,000 | $5.14 | $10.3K | 0 |
| Dec 31, 2021 | Hammacher Alex | Director | Buy | 1,000 | $10.86 | $10.9K | 0 |
| Dec 22, 2021 | Wright Robin | Director | Buy | 10,000 | $9.97 | $99.7K | 0 |
| May 4, 2021 | DAWES KAREN A | Director | Buy | 1,700 | $17.00 | $28.9K | 0 |
| May 4, 2021 | Ellis Christopher | Chief Operating Officer | Buy | 75 | $17.00 | $1.3K | 0 |
| May 4, 2021 | Griffiths Graham | Chief Business Officer | Buy | 100 | $17.00 | $1.7K | 0 |
| May 4, 2021 | Oxford Sciences Innovation plc | 10% Owner | Buy | 600,000 | $17.00 | $10.20M1.5% OS | 0 |
| May 4, 2021 | Scheeren Joseph | Director | Buy | 3,000 | $17.00 | $51.0K | 0 |
| May 4, 2021 | Wright Robin | Director | Buy | 14,000 | $17.00 | $238.0K | 0 |
BRNS Insider Buying Activity
The following table shows recent insider purchases of Barinthus Biotherapeutics plc (BRNS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | Scheeren Joseph | Director | Buy | 10,000 | $2.44 | $24.4K | 0 |
| May 25, 2023 | Wright Robin | Director | Buy | 13,750 | $2.66 | $36.6K | 0 |
| Apr 1, 2022 | Scheeren Joseph | Director | Buy | 10,000 | $5.09 | $50.9K | 0 |
| Mar 31, 2022 | Hammacher Alex | Director | Buy | 2,000 | $5.14 | $10.3K | 0 |
| Dec 31, 2021 | Hammacher Alex | Director | Buy | 1,000 | $10.86 | $10.9K | 0 |
| Dec 22, 2021 | Wright Robin | Director | Buy | 10,000 | $9.97 | $99.7K | 0 |
| May 4, 2021 | DAWES KAREN A | Director | Buy | 1,700 | $17.00 | $28.9K | 0 |
| May 4, 2021 | Ellis Christopher | Chief Operating Officer | Buy | 75 | $17.00 | $1.3K | 0 |
| May 4, 2021 | Griffiths Graham | Chief Business Officer | Buy | 100 | $17.00 | $1.7K | 0 |
| May 4, 2021 | Oxford Sciences Innovation plc | 10% Owner | Buy | 600,000 | $17.00 | $10.20M1.5% OS | 0 |
| May 4, 2021 | Scheeren Joseph | Director | Buy | 3,000 | $17.00 | $51.0K | 0 |
| May 4, 2021 | Wright Robin | Director | Buy | 14,000 | $17.00 | $238.0K | 0 |
BRNS Insider Selling Activity
The following table shows recent insider sales of Barinthus Biotherapeutics plc (BRNS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 27, 2023 | Enright William | Chief Executive Officer | Sell | 15,000 | $2.42 | $36.3K | 0 |
| Aug 25, 2022 | Griffiths Graham | Chief Business Officer | Sell | 10,000 | $7.39 | $73.9K | 0 |
| Aug 24, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 39,626 | $6.55 | $259.5K | 0 |
| Aug 17, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 2,824 | $4.82 | $13.6K | 0 |
| Aug 17, 2022 | Griffiths Graham | Chief Business Officer | Sell | 500 | $4.76 | $2.4K | 0 |
| Aug 15, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 7,550 | $4.77 | $36.0K | 0 |
| Aug 15, 2022 | Griffiths Graham | Chief Business Officer | Sell | 3,620 | $4.77 | $17.3K | 0 |
| Aug 12, 2022 | Griffiths Graham | Chief Business Officer | Sell | 5,000 | $4.50 | $22.5K | 0 |
| Jun 28, 2022 | Ellis Christopher | Chief Operating Officer | Sell | 5 | $6.00 | $30.00 | 0 |
| Jun 23, 2022 | Griffiths Graham | Chief Business Officer | Sell | 108 | $5.82 | $629.04 | 0 |
BRNS Insiders
Similar Stocks to BRNS
VRTX
Vertex Pharmaceuticals Incorporated
$512.33+0.78%
$131.05B
REGN
Regeneron Pharmaceuticals, Inc.
$799.66+2.05%
$81.33B
MRNA
Moderna, Inc.
$169.05+9.77%
$61.12B
RVMD
Revolution Medicines, Inc.
$192.38+0.67%
$41.87B
INSM
Insmed Incorporated
$122.77+2.30%
$26.01B
INCY
Incyte Corporation
$125.36+0.10%
$25.40B
UTHR
United Therapeutics Corporation
$494.53+0.02%
$21.00B
NBIX
Neurocrine Biosciences, Inc.
$143.93-1.57%
$14.70B